| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |